These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities. Thomas SR; Witting PK; Drummond GR Antioxid Redox Signal; 2008 Oct; 10(10):1713-65. PubMed ID: 18707220 [TBL] [Abstract][Full Text] [Related]
3. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Cai H; Harrison DG Circ Res; 2000 Nov; 87(10):840-4. PubMed ID: 11073878 [TBL] [Abstract][Full Text] [Related]
4. Sickle cell disease: role of reactive oxygen and nitrogen metabolites. Wood KC; Granger DN Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):926-32. PubMed ID: 17645642 [TBL] [Abstract][Full Text] [Related]
8. Nitric oxide and oxidative stress in vascular disease. Förstermann U Pflugers Arch; 2010 May; 459(6):923-39. PubMed ID: 20306272 [TBL] [Abstract][Full Text] [Related]
9. Oxidative stress, nitric oxide synthase, and superoxide dismutase: a matter of imbalance underlies endothelial dysfunction in the human coronary circulation. Schiffrin EL Hypertension; 2008 Jan; 51(1):31-2. PubMed ID: 18071058 [No Abstract] [Full Text] [Related]
12. Oxidative stress and mitochondrial dysfunction in atherosclerosis: mitochondria-targeted antioxidants as potential therapy. Victor VM; Apostolova N; Herance R; Hernandez-Mijares A; Rocha M Curr Med Chem; 2009; 16(35):4654-67. PubMed ID: 19903143 [TBL] [Abstract][Full Text] [Related]
13. Antioxidants and the bioactivity of endothelium-derived nitric oxide. Tomasian D; Keaney JF; Vita JA Cardiovasc Res; 2000 Aug; 47(3):426-35. PubMed ID: 10963716 [No Abstract] [Full Text] [Related]
14. Differential regulation of xanthine and NAD(P)H oxidase by hypoxia in human umbilical vein endothelial cells. Role of nitric oxide and adenosine. Sohn HY; Krotz F; Gloe T; Keller M; Theisen K; Klauss V; Pohl U Cardiovasc Res; 2003 Jun; 58(3):638-46. PubMed ID: 12798437 [TBL] [Abstract][Full Text] [Related]
15. Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Spiekermann S; Landmesser U; Dikalov S; Bredt M; Gamez G; Tatge H; Reepschläger N; Hornig B; Drexler H; Harrison DG Circulation; 2003 Mar; 107(10):1383-9. PubMed ID: 12642358 [TBL] [Abstract][Full Text] [Related]
16. Oxidative stress and vascular function: implications for pharmacologic treatments. Weseler AR; Bast A Curr Hypertens Rep; 2010 Jun; 12(3):154-61. PubMed ID: 20424954 [TBL] [Abstract][Full Text] [Related]
17. Reactive oxygen species and endothelial function--role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases. Montezano AC; Touyz RM Basic Clin Pharmacol Toxicol; 2012 Jan; 110(1):87-94. PubMed ID: 21883939 [TBL] [Abstract][Full Text] [Related]
18. Oxidative Stress and Hypertensive Diseases. Loperena R; Harrison DG Med Clin North Am; 2017 Jan; 101(1):169-193. PubMed ID: 27884227 [TBL] [Abstract][Full Text] [Related]
19. Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production. Wassmann S; Laufs U; Stamenkovic D; Linz W; Stasch JP; Ahlbory K; Rösen R; Böhm M; Nickenig G Circulation; 2002 Apr; 105(17):2083-91. PubMed ID: 11980689 [TBL] [Abstract][Full Text] [Related]
20. Cross talk between mitochondria and NADPH oxidases. Dikalov S Free Radic Biol Med; 2011 Oct; 51(7):1289-301. PubMed ID: 21777669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]